InspireMD Announces Updated Timing for Third Quarter 2026 Financial Results

MIAMI, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard(®) Prime carotid stent system for the prevention of stroke, today announced that it has rescheduled its third quarter 2026 financial results conference call and webcast to 4:30 p.m. Eastern Time, after the close of U.S. financial markets on Thursday, November 12, 2026, from its previously announced time of 8:30 a.m. Eastern Time.

The revised timing will allow management to provide investors with a more comprehensive update on the Company’s recent developments and business activities in conjunction with its third quarter financial results.